Ama launches independent vaccine review after CDC criticism / Medical Express

medicalxpress - Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #cdc #vaccinesafety

Vaccine denial sets Americans up for more chronic illness

29 days / livescience

Large study finds no link between mRNA COVID vaccine in pregnancy and autism

29 days / sciencedaily

Ama launches independent vaccine review after CDC criticism

4 wks / medicalxpress

AMA partners with research group to review vaccine safety, effectiveness

4 wks / beckershospitalreview / Mackenzie Bean

Saturday, February 14, 2026, 12:22 am / permalink 19173 / 4 stories in 4 wks

Related Stories

NIH director Jay Bhattacharya named acting CDC chief temporarily / 26 days
CDC revises childhood vaccine schedule by cutting six vaccines / 2 months
CDC Ends Universal Hepatitis B Newborn Vaccination / 2 months
Hepatitis B Vaccine Schedule Under Review / 3 months
ACIP Drops Universal Hepatitis B Birth Dose for Newborns / 3 months
Measles resurgence raises risk of rare fatal neurological complication / 2 days
RFK appoints two new members to CDC vaccine advisory panel ahead of meeting / 14 days

Related Tags

Healthcare

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (16 hrs)

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (19 hrs)

more #healthcare

Pharmaceuticals

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (20 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)

more #pharmaceuticals

Public Health

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (19 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)

AI improves UK breast-screening detection by about 10% (2 days)

more #publichealth

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.